Released Aug 5, 2019, after the close
10-Q filed Aug 5, 2019, 36 days after period end · 0001564590-19-028764
Q2 2019 · 10-Q
Revenue$115.85M$115.85M +3.9% vs Q2 2018+6.2% vs Q1 2019
Net Income-$547.00K-$547.00K N/M vs Q2 2018N/M vs Q1 2019
EPS Diluted-$0.03-$0.03 N/M vs Q2 2018N/M vs Q1 2019
Gross Profit$90,038,000+1.5%
Operating Income$451,000−92.4%
Operating Cash Flowderived$9,383,000−43.4%
Free Cash Flowderived$4,431,000−67.5%
Margins · derived
Gross margin77.7%−1.8 pt vs Q2 2018
Operating margin0.4%−4.9 pt vs Q2 2018
Net margin-0.5%−1.3 pt vs Q2 2018
What the release said
The release
Same quarter
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $115.85M | $111.55M | $108.94M | $104.08M |
| Net Income | -$547.00K | $925.00K | $3.85M | -$7.44M |
| EPS Diluted | -$0.03 | $0.05 | $0.21 | -$0.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR